Fosun Pharma
Shanghai Fosun Pharmaceutical (Group) Co., Ltd., operating under trade name Fosun Pharma, is a Chinese pharmaceutical company based in Shanghai, China.
History
COVID-19
On March 17, 2020, Fosun granted a $135 million investment to BioNTech in exchange for 1.58 million shares in BioNTech and the future development and marketing rights of the mRNA vaccine BNT162b2 in China.1)
External links
1)
BioNTech in China alliance with Fosun over coronavirus vaccine candidate. (2020, March 16). Reuters. https://web.archive.org/web/20220720182255/https://www.reuters.com/article/biontech-fosunpharma-vaccine-collaborati/biontech-in-china-alliance-with-fosun-over-coronavirus-vaccine-candidate-idUSL8N2B90UW